Quelle

Literatura:
Yunqi Weng
,
Jian Yao
,
Sawyer Sparks
, Kevin Yueju Wang. Nattokinase, An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease,
Int J Mol Sci
, 2017 Mar; 18(3): 523,
Gitte S. Jensen
,
Miki Lenninger
,
Michael P Ero
,
Kathleen F Benson
. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial,
Integr Blood Press Control
. 2016; 9: 95–104,
Yuko Kurosawa
,
Shinsuke Nirengi
,
Toshiyuki Homma
,
Kazuki Esaki
,
Mitsuhiro Ohta
,
Joseph F. Clark
, Takafumi Hamaoka, A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles,
Sci Rep
. 2015; 5: 11601,
Lampe B.J
.,
English J.C
., Toxicological assessment of nattokinase derived from Bacillus subtilis var. natto,
Food Chem Toxicol
, 2016 Feb;88:87-99.